Julie K Silver1, Jennifer Baima1, Robin Newman2, Mary Lou Galantino3, Lillie D Shockney4. 1. Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA. 2. Department of Occupational Therapy, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA. 3. School of Health Sciences, The Richard Stockton College of New Jersey, Galloway, NJ, USA. 4. Departments of Surgery, Oncology and Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract
BACKGROUND: Cancer and its treatment may cause physical impairments and psychological distress in survivors. Rehabilitation is a critical component of quality cancer care, returning survivors to their highest functional potential. OBJECTIVE: This overview focuses on the benefits of multidisciplinary cancer rehabilitation - including improving physical function, reducing psychological distress, promoting return to work and, therefore, decreasing the economic burden of cancer and its treatment on individuals and society in general. METHODS: Relevant literature was identified through a search of the PubMed database and reviewed for its relevance to cancer rehabilitation and the topic of this article. Search terms included, but were not limited to, cancer rehabilitation, cancer prehabilitation, disability, return to work, employment, and unemployment. RESULTS: Cancer survivors are less likely to be employed and take more sick leave than workers without a history of cancer. Pain, musculoskeletal issues, deconditioning, fatigue, balance, psychosocial issues, and lymphedema are most amenable to rehabilitation. CONCLUSION: Overall health and the need for work accommodations must be addressed in order to improve return to work and subsequent productivity in cancer survivors. Survivors are usually best served by a multidisciplinary care team comprising members who can address the myriad impairments affecting survivor function.
BACKGROUND:Cancer and its treatment may cause physical impairments and psychological distress in survivors. Rehabilitation is a critical component of quality cancer care, returning survivors to their highest functional potential. OBJECTIVE: This overview focuses on the benefits of multidisciplinary cancer rehabilitation - including improving physical function, reducing psychological distress, promoting return to work and, therefore, decreasing the economic burden of cancer and its treatment on individuals and society in general. METHODS: Relevant literature was identified through a search of the PubMed database and reviewed for its relevance to cancer rehabilitation and the topic of this article. Search terms included, but were not limited to, cancer rehabilitation, cancer prehabilitation, disability, return to work, employment, and unemployment. RESULTS:Cancer survivors are less likely to be employed and take more sick leave than workers without a history of cancer. Pain, musculoskeletal issues, deconditioning, fatigue, balance, psychosocial issues, and lymphedema are most amenable to rehabilitation. CONCLUSION: Overall health and the need for work accommodations must be addressed in order to improve return to work and subsequent productivity in cancer survivors. Survivors are usually best served by a multidisciplinary care team comprising members who can address the myriad impairments affecting survivor function.
Entities:
Keywords:
Return to work; cancer-related impairments; disability; prehabilitation; survivorship
Authors: Julie K Silver; Vishwa S Raj; Jack B Fu; Eric M Wisotzky; Sean Robinson Smith; Rebecca A Kirch Journal: Support Care Cancer Date: 2015-08-28 Impact factor: 3.603
Authors: Jack B Fu; Melissa P Osborn; Julie K Silver; Benedict S Konzen; An Ngo-Huang; Rajesh Yadav; Eduardo Bruera Journal: Am J Phys Med Rehabil Date: 2017-07 Impact factor: 2.159
Authors: Mackenzi Pergolotti; Allison M Deal; Grant R Williams; Ashley L Bryant; Lauren McCarthy; Kirsten A Nyrop; Kelley R Covington; Bryce B Reeve; Ethan Basch; Hyman B Muss Journal: J Am Geriatr Soc Date: 2019-05 Impact factor: 5.562
Authors: John H Alexander; Sumanas W Jordan; Julie M West; Amy Compston; Jennifer Fugitt; J Byers Bowen; Gregory A Dumanian; Raphael Pollock; Joel L Mayerson; Thomas J Scharschmidt; Ian L Valerio Journal: J Surg Oncol Date: 2019-06-13 Impact factor: 3.454